Searched for
JAPANESE DAIICHI SANKYO
NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...- After 50 hearings, court reserves judgement in Daiichi-Fortis caseThe Delhi High Court has reserved its judgment in a significant arbitration case. Japanese drug maker Daiichi Sankyo is seeking to enforce ...
- Fortis liability case: Delhi HC says blame can't be shifted to third partyAmid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the S...
- Tokyo Court to rule on Fortis arm IHH and Daiichi Sankyo disputeA significant legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. The Tokyo District Court will announce its jud...
- IHH-Daiichi legal battle nears verdict on September 10A major legal battle between IHH Healthcare and Daiichi Sankyo is reaching its climax. IHH's subsidiary, NTK, is seeking JPY 200 billion in...
- Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
- Daiichi comments continue to damage interests: IHH UnitNorthern TK Venture, a subsidiary of IHH Healthcare, has increased its legal claim against Daiichi Sankyo. The claim is now for ₹11,800 cro...
- Ranbaxy, Daiichi Sankyo to collaborate in Brazil to expand businessIn Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil.
- Daiichi to use Ranbaxy network to sell products in SingaporeRanbaxy and Daiichi Sankyo had signed a three-year plan to exploit synergies in operations to enhance their generic as well as branded busi...
- Ranbaxy to shift focus from new drug research to genericsRanbaxy Laboratories has said it is shifting the focus of its research from the development of new drugs to that of generic drugs for effec...
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
- FIPB rejects Zenotech plea against DaiichiThe country’s foreign investment regulator has rejected a plea by Zenotech Laboratories seeking the withdrawal of its earlier ruling that a...
- Daiichi to meet US FDA to resolve Ranbaxy issueDaiichi Sankyo, the Japanese pharmaceutical company that bought Ranbaxy Laboratories last year, will meet US FDA officials next month to so...
- Daiichi to meet FDA, launches 1st drug through RanbaxyDaiichi Sankyo, the new owner of Ranbaxy Laboratories will meet US Food and Drugs Administration (FDA) officials next month to sort out the...
- Zenotech: Daiichi refuses to revise open offer priceDaiichi Sankyo, the new promoter of Ranbaxy, plans to buy 20% stake in Hyderabad-based Zenotech Labs has run into trouble after the Japanes...
- Re fall helps Daiichi save $880 mn in its $4-billion Ranbaxy buyoutThe sharp depreciation of the Indian rupee against the Japanese yen and the dollar helped Japanese drug company Daiichi Sankyo save around ...
- Daiichi Sankyo on course to complete Ranbaxy buyDaiichi Sankyo is all set to close the $4.6-bn acquisition of the country’s largest drugmaker Ranbaxy Laboratories.
- Ranbaxy, Daiichi Sankyo confirm deal; allay market rumoursA day after Ranbaxy Laboratories accused the corporate rivals for the recent stock slump, the pharma major today said its deal to sell prom...
- Daiichi gets a foothold in IndiaDaiichi Sankyo’s buyout of Ranbaxy has paved the way for the $8.2 bn drug discovery company to acquire one of the world’s largest generic p...
- Japan's Daiichi to set up manufacturing, research unitThe $8-billion Daiichi Sankyo Company, Japan’s second-largest pharma company, is in the process of setting up a full-fledged manufacturing ...
Load More
